PharmiWeb.com - Global Pharma News & Resources
13-Dec-2018

Somatostatin Receptor Agonist Pipeline Insight Report, 2018 - ResearchAndMarkets.com

The "Somatostatin Receptor Agonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Somatostatin Receptor Agonist - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Somatostatin Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Somatostatin Receptor Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Somatostatin Receptor Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Somatostatin Receptor Agonist - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Somatostatin Receptor Agonist

4. Comparative Analysis

5. Somatostatin Receptor Agonist Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

6. Somatostatin Receptor Agonist Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Product Description
  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • Crinetics Pharmaceuticals
  • Camurus
  • Chiasma
  • Novartis
  • GP Pharm
  • Peptor
  • Ipsen

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vns6x5/somatostatin?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005889/en/

Editor Details

Last Updated: 13-Dec-2018